We are live on ! Find out more
ASD

Defiance Autism Impact ETF

Positive
Neutral
Negative
Sentiment 3-Months
Positive 37.5%
Neutral 62.5%
Negative 0%

Neutral
ETF Trends
21 days ago
No Summer Solstice for ETFs: June Records Cap Off a Blockbuster First Half
The arrival of June usually signals a seasonal slowdown for many people, but our ETF industry clearly missed the memo. Instead of heading to the beach or stopping to watch the World Cup, the ETF ecosystem had a wave of milestones, structural changing-of-the-guards, and high-profile index provider consolidation.
No Summer Solstice for ETFs: June Records Cap Off a Blockbuster First Half
Neutral
ETF Trends
27 days ago
A Roundup of June's Most Notable ETF Launches
June has seen many ETF launches, from pure-play AI memory chip thematics to an autism impact fund that donates returns to nonprofits. With a record breaking 214 launches, the ETF landscape continues to expand into new markets.
A Roundup of June's Most Notable ETF Launches
Neutral
ETF Trends
27 days ago
How 2026's Philanthropic ETFs ASD & DUTY Invest
The ETF ecosystem is always changing and growing. Thanks to the ETF's flexibility, transparency, and tradability, it can help investors achieve plenty of bespoke goals.
How 2026's Philanthropic ETFs ASD & DUTY Invest
Neutral
GlobeNewsWire
1 month ago
MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder
SAN FRANCISCO and BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, today announced topline results from IRIS (ML-004-002), a Phase 2 study of ML-004 in autism spectrum disorder (ASD). The study randomized 161 participants (102 adolescents, 59 adults), with prespecified analyses planned by age group and baseline irritability severity.
MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder
Positive
ETF Trends
1 month ago
Inside ASD: The Story Behind the First Autism ETF
The Defiance Autism Impact ETF (ASD) launched June 1 as the first fund built entirely around companies tied to autism care. Behind it is a personal story from inside the firm itself.
Inside ASD: The Story Behind the First Autism ETF
Positive
ETF Trends
1 month ago
ETF Prime: Defiance Launches First-Ever Autism ETF
The first-ever autism ETF and the continued rise of quantum computing were both in the spotlight on this week's ETF Prime. Host Nate Geraci welcomed Sylvia Jablonski, chief investment officer of Defiance ETFs, to discuss the firm's latest launch and one of the market's top-performing funds.
ETF Prime: Defiance Launches First-Ever Autism ETF
Positive
ETF Trends
1 month ago
Week of June 1's Top Stories Covered SpaceX IPO, First Autism ETF
Last week's top articles on ETF Database and ETF Trends were closely connected to current events such as SpaceX's expected IPO and tech stock performance. The most-read article last week was “SpaceX IPO to Boost Aerospace ETFs?
Week of June 1's Top Stories Covered SpaceX IPO, First Autism ETF
Neutral
ETF Trends
1 month ago
Investing With Purpose: Defiance Launches Autism Impact ETF
With over 5,000 funds and many launching daily in the exchange-traded fund (ETF) universe, there are a select few that can capture both industrial utility and deep human significance.
Investing With Purpose: Defiance Launches Autism Impact ETF